Potential Treatment of Sepsis Syndrome with Cytokine-Specific Agents (Q36378658)

13 August 2017

1 reference

title

Potential treatment of sepsis syndrome with cytokine-specific agents (English)

1 reference

13 August 2017

Potential Treatment of Sepsis Syndrome with Cytokine-Specific Agents (English)

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

Cardiology and cardiovascular medicine

20 October 2022

main subject

sepsis

0 references

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

20 October 2022

author name string

J. W. Christman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1643955

20 October 2022

language of work or name

English

0 references

publication date

1 August 1992

1 reference

full work available at URL

13 August 2017

https://api.elsevier.com/content/article/PII:S0012369216340739?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

https://api.elsevier.com/content/article/PII:S0012369216340739?httpAccept=text/plain

20 October 2022

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

20 October 2022

1 reference

13 August 2017

102

1 reference

13 August 2017

2

1 reference

13 August 2017

613-617

1 reference

Molecular cloning of the complementary DNA for human tumor necrosis factor.

13 August 2017

1

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs

20 October 2022

2

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

Nucleotide sequence of human monocyte interleukin 1 precursor cDNA

20 October 2022

3

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

Structure and expression of a cloned cDNA for human interleukin-2.

20 October 2022

4

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

Isolation and characterization of a mouse interleukin cDNA clone that expresses B-cell stimulatory factor 1 activities and T-cell- and mast-cell-stimulating activities

20 October 2022

5

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

Isolation and characterization of a human interleukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, that expresses B-cell- and T-cell-stimulating activities

20 October 2022

7

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor

20 October 2022

8

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor

20 October 2022

9

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

Molecular cloning and expression of a receptor for human tumor necrosis factor

20 October 2022

10

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor

20 October 2022

11

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins

20 October 2022

12

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily

20 October 2022

13

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

Cloning the interleukin 1 receptor from human T cells

20 October 2022

14

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

Interleukin-2 receptor beta chain gene: generation of three receptor forms by cloned human alpha and beta chain cDNA's

20 October 2022

16

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

Human interleukin 4 receptor confers biological responsiveness and defines a novel receptor superfamily

20 October 2022

17

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms.

20 October 2022

18

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

Expression cloning of a cDNA encoding the murine interleukin 4 receptor based on ligand binding

20 October 2022

19

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor

20 October 2022

20

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor

20 October 2022

21

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

Specific interleukin-1 inhibitor in serum and urine of children with systemic juvenile chronic arthritis

20 October 2022

25

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin

20 October 2022

26

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

20 October 2022

27

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia

20 October 2022

28

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

Divergent efficacy of antibody to tumor necrosis factor-alpha in intravascular and peritonitis models of sepsis

20 October 2022

29

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

Prevention of human TNF-induced cutaneous Shwartzmann reaction and acute mortality in mice treated with anti-human TNF monoclonal antibodies

20 October 2022

30

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

Monoclonal antibody to TNF in severe septic shock

20 October 2022

31

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

Conversion of the interleukin 1 receptor antagonist into an agonist by site-specific mutagenesis

20 October 2022

33

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody

20 October 2022

34

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

Two high-affinity interleukin 1 receptors represent separate gene products

20 October 2022

35

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

In the mouse, the activation of the hypothalamic-pituitary-adrenal axis by a lipopolysaccharide (endotoxin) is mediated through interleukin-1.

20 October 2022

36

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

Interleukin 1 receptor blockade attenuates the host inflammatory response

20 October 2022

38

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

Soluble cytokine receptors are present in normal human urine

20 October 2022

43

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

Complementary DNA cloning of a receptor for tumor necrosis factor and demonstration of a shed form of the receptor

20 October 2022

44

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

Cloning of human tumor necrosis factor (TNF) receptor cDNA and expression of recombinant soluble TNF-binding protein

20 October 2022

45

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

Soluble forms of tumor necrosis factor receptors (TNF-Rs). The cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor

20 October 2022

46

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor

20 October 2022

47

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

Shedding of tumor necrosis factor receptors by activated human neutrophils

20 October 2022

50

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

An interleukin-1 receptor antagonist blocks lipopolysaccharide-induced colony-stimulating factor production and early endotoxin tolerance.

20 October 2022

52

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

20 October 2022

56

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist

20 October 2022

57

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

Characterization of a specific 20- to 25-kD interleukin-1 inhibitor from cultured human lung macrophages

20 October 2022

58

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

Interleukin-1 receptor antagonist reduces mortality from endotoxin shock

20 October 2022

59

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

A specific receptor antagonist for interleukin 1 prevents Escherichia coli ‐induced shock in rabbits

20 October 2022

60

1 reference

https://api.crossref.org/works/10.1378/CHEST.102.2.613

20 October 2022

Identifiers

1 reference

13 August 2017

1 reference